SCHEMBL12759658

SCHEMBL12759658

Cc1cc(-c2ccccc2)cc(C)c1-c1cnc2c3ccccc3c3ccccc3n12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.37
GSK3B P49841 1/20 0.35
KDM4E B2RXH2 3/20 0.34
HPGD P15428 2/20 0.34
ALDH1A1 P00352 1/20 0.34
PSMB5 P28074 1/20 0.34
HSD17B10 Q99714 3/20 0.33
CYP17A1 P05093 2/20 0.33
CYP1A2 P05177 2/20 0.33
FLT3 P36888 1/20 0.33
TSHR P16473 1/20 0.33
PTGER4 P35408 2/20 0.33
MAPT P10636 2/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CHEK1 O14757 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL841028 0.90 GSK3B (0.33) GSK3BKDM4EALDH1A1PSMB5CYP17A1
SCHEMBL21917735 0.88 PTGER4 (0.35) POLBKDM4EHPGDALDH1A1PSMB5
SCHEMBL12759482 0.85 ALKBH5 (0.39) POLBKDM4EHPGDALDH1A1HSD17B10
SCHEMBL18897831 0.81 KDM4E (0.43) POLBGSK3BKDM4EHPGDALDH1A1
SCHEMBL21917733 0.81 PTGER4 (0.34) PSMB5CYP1A2FLT3PTGER4MAPT
SCHEMBL841622 0.80 POLB (0.36) POLBGSK3BKDM4EHPGDALDH1A1
SCHEMBL19606113 0.79 GSK3B (0.32) GSK3BPSMB5CYP17A1CYP1A2FLT3
SCHEMBL12759654 0.79 PGR (0.38) KDM4EALDH1A1PSMB5CYP1A2MAPT
SCHEMBL16482324 0.79 POLB (0.42) POLBGSK3BKDM4EHPGDALDH1A1
SCHEMBL16482359 0.78 GPR3 (0.37) POLBKDM4EHPGDALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2015-10-29 US disclosed
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2015-10-29 US disclosed
US-9062084-B2 Method of forming metal complex compound, and organic electroluminescence device UDC Ireland (IE) 2015-06-23 US disclosed
US-9062084-B2 Method of forming metal complex compound, and organic electroluminescence device UDC Ireland (IE) 2015-06-23 US disclosed
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE ZFR, PORCN, OR10J3 POLB 1381/4885GSK3B 4746/4885KDM4E 2514/4885
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device ZFR, PORCN, OR10J3 POLB 1381/4885GSK3B 4746/4885KDM4E 2514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.